Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

TransMedics (TMDX) Receivables - Net (2018 - 2025)

TransMedics has reported Receivables - Net over the past 8 years, most recently at $84.3 million for Q4 2025.

  • Quarterly results put Receivables - Net at $84.3 million for Q4 2025, down 13.75% from a year ago — trailing twelve months through Dec 2025 was $84.3 million (down 13.75% YoY), and the annual figure for FY2025 was $84.3 million, down 13.75%.
  • Receivables - Net for Q4 2025 was $84.3 million at TransMedics, up from $80.7 million in the prior quarter.
  • Over the last five years, Receivables - Net for TMDX hit a ceiling of $142.0 million in Q1 2025 and a floor of $4.1 million in Q3 2021.
  • Median Receivables - Net over the past 5 years was $54.1 million (2023), compared with a mean of $53.6 million.
  • Biggest five-year swings in Receivables - Net: crashed 32.42% in 2021 and later surged 430.96% in 2022.
  • TransMedics' Receivables - Net stood at $5.9 million in 2021, then surged by 365.3% to $27.6 million in 2022, then surged by 130.26% to $63.6 million in 2023, then skyrocketed by 53.71% to $97.7 million in 2024, then decreased by 13.75% to $84.3 million in 2025.
  • The last three reported values for Receivables - Net were $84.3 million (Q4 2025), $80.7 million (Q3 2025), and $104.9 million (Q2 2025) per Business Quant data.